About ERIX
EiRx Therapeutics is a specialist provider of pre-clinical therapeutics to the pharmaceutical industry. Our unique scientific expertise and knowledge in the field of Apoptosis provide a sound base to discover and develop new medicines that will safely and selectively repair this natural process in disease. The potential benefits from these new medicines are enormous, since as many as 70% of all human disease have some defect in the control of Apoptosis.
Apoptosis - the biological process that determines whether cells in our bodies live or die...
http://www.eirx.com/index.html

Purchased some of these on the strength of the PROGRESS UPDATE looks promising.
http://moneyam.uk-wire.com/cgi-bin/articles/200603200701130254A.html

ERX interview with John Pool
http://www.wallstreetreporter.com/interview.php?id=18589&player=real
Latest News
CANCER COLLABORATION WITH BIOMERIEUX SA
http://moneyam.uk-wire.com/cgi-bin/articles/200607120700230534G.html
Biomerieux Web Site
http://www.biomerieux.com/servlet/srt/bio/portail/home
ABOUT ERX Focus Of The Month
http://www.billamag.net/focus-document-text.asp?FocusTextID=1
ERX pdf filehttp://www.eirx.com/eirx_heading_images/Yokohama2005.pdf
19/09/2006 A 50% reduction in breast tumour volume size seen with Eirx lead molecule in animal studies
http://moneyam.uk-wire.com/cgi-bin/articles/200609190700171175J.html

Past and present collaborative partners include:

* bioMieux SA
* Almac Diagnostics Ltd
* Merck & Co, Ltd
* Biofocus plc
* MGI Pharmaceuticals, Inc
* OSI Pharmaceuticals, Inc
* Sareum plc
* Regen Therapeutics plc
* SR Pharma plc

Discovery on Target 2006
..................................................................................................................................
Dr. Finbarr Murphy, Managing Director, EiRx Therapeutics Ltd. is attending Discovery on Target 2006 in Boston from October 23-26, 2006 at the World Trade Center, Boston, MA, USA.
Dr. Murphy will take part in the Roundtable Buzz Session on Wednesday 25th and will also speak on "siRNA and the Problem of Getting What You Want" on Thursday 26th @ 11.35am.

For further information on this event please click here

http://www.eirx.com/eirx%5Fpages/

smiler
Nice one I will have to check the Web Site more often.

Further information on Discovery on Target 2006

http://www.eirx.com/eirx%5Fpages/

ERX is on the up with the Discovery on Target 2006 Conference news.

Driver

17.95 % might make some money out of this yet !

smiler
38% up and still going you should start making soon.

Driver

Got 200000 at .23

Driver

Some big buys today share wise ?? is there some news in the pipe line you think !

smiler
The rumour is that news is coming I would take that with a pinch of salt , I would say the Discovery on Target 2006 Conference and the rumour has stirred things up a bit.
News will come in time then hopefully we will see a steady increase in the sp.

Lots of trades today with some biggish volumes, lets see what tomorrow brings.

driver

typical i am back at work tomorrow and will not get in till 2000 hrs, something is bound to happen !!

Hold on to your hats

EIRX THERAPEUTICS PLC
('EiRx' or 'the Company')

A 50% reduction in breast tumour volume size seen with Eirx lead molecule in
animal studies
'A reduction in tumour volume of 50% is seen by the National Cancer Institute in
America, and other leading authorities as being highly significant' said
Professor Tom Cotter, founder and CSO of EiRx. 'We are now in active
discussions with a developmental company to further develop this molecule and to
prepare it for a future phase 1 clinical trial.

Commenting on the results, Dr. Finbarr Murphy, Managing Director of operating
subsidiary EiRx Therapeutics Ltd, said: 'The efficacy and selectivity of the
molecule is very encouraging, and supports our approach of targeted apoptosis
therapy in the treatment of cancer to limit toxicity and side effects associated
with standard chemotherapy.

http://moneyam.uk-wire.com/cgi-bin/articles/200609190700171175J.html

The sky is the limit on this one with such a small M/Cap and the market for breast cancer drugs at $6.2 billion; ERX could easy go to 10p in the long term IMO

For smiler up 42% at 0820

Highlights from today's RNS


Significant 50% reduction in tumour volume

'A reduction in tumour volume of 50% is seen by the National Cancer Institute in
America, and other leading authorities as being highly significant'

The mice did not show any toxic or side effects, such as
weight loss, associated with compound administration. This suggests that the
compound is highly selective for the tumour, unlike the more traditional cancers
therapies, where effectiveness can be limited due to associated toxicities.

Professor Tom Cotter, founder and CSO of EiRx. 'We are now in active
discussions with a developmental company to further develop this molecule and to
prepare it for a future phase 1 clinical trial.

With an estimated 112,000 dying from the disease.
The incidence is forecast to increase annually at an average rate of 3%. The size
of the market for breast cancer drugs is $6.2 billion; representing 17% of the
total spend of the cancer market.

hello driver

plm2349
Hi, are you still on these.

there is more news on thursday.. I reckon it will be better than todays news

driver of course!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

PH
Thanks Cannoncan.

A nice 23% up with steady buying today thats OK by me, better than pump and dump. Onwards and upwards tomorrow.